�山ǿ�� News - antibodies

YCharOS forms key industry advisory committee and releases first open data

webfull — Tue, 22 Jun 2021 13:11:32 +0000

Leading antibody reagent and knockout cell line manufacturers team up to address life science reproducibility crisis

YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, is pleased to announce the publication of its first characterization data and formation of its Industry Advisory Committee (IAC).

Published: 22 June 2021

New study offers first glimpse into how widespread COVID-19 antibodies are in Canada’s adult population

webfull — Thu, 23 Jul 2020 13:00:49 +0000

Today, Canadian Blood Services and Canada’s COVID-19 Immunity Task Force (CITF) are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus.

Published: 23 July 2020

Improving research with more effective antibodies

webfull — Tue, 15 Oct 2019 16:55:16 +0000

Scientists demonstrate flaws in protein detection tools, and outline a solution

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.

Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate information from an organism’s genes into the structure, function, and regulation of its tissues and organs. Genetic mutations can cause protein imbalances or malfunctions, leading to human disease.

Published: 15 October 2019